Synapse - Ayca Gucalp

Results (31)

A phase 1/2 study of once-daily oral VT-464 in patients with advanced androgen receptor (AR) positive triple negative (TNBC) or estrogen receptor (ER) positive breast cancer (BC)

Meeting Abstract

Gucalp, A.; Hudis, C.; Norton, L.; Patil, S.; Kurman, M. R.; Eisner, J. R.; Moore, W. R.; Traina, T. A.
Cancer Research (2016)

Fulltext@MSK | Save

Prevalence of hypomagnesemia in patients with HER2-positive breast cancer receiving pertuzumab treatment

Meeting Abstract

Proverbs-Singh, T. A.; Cadoo, K. A.; Torre, G.; Patil, S.; Gucalp, A.; Dang, C. T.; Hudis, C. A.; Glezerman, I. G.; Traina, T. A.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer

Journal Article

Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K.; Rugo, H.; Nabell, L.; Forero, A.; more...
Clinical Cancer Research (2013)

Fulltext@MSK | Save

A pilot study of single-dose ipilimumab and/or cryoablation in women with early-stage breast cancer scheduled for mastectomy

Meeting Abstract

Diab, A.; McArthur, H. L.; Solomon, S.; Comstock, C.; Maybody, M.; Sacchini, V.; Durack, J.; Gucalp, A.; Yuan, J.; Patil, S.; more...
Cancer Research (2012)

Fulltext@MSK | Save

Evaluation of the prognostic significance of androgen receptor (AR) expression in relation to ER expression in breast cancer (BC)

Meeting Abstract

Gucalp, A.; Datko, F. M.; Patil, S.; Hedvat, C. V.; Kalinsky, K.; Hudis, C. A.; Traina, T. A.; Moynahan, M. E.
Cancer Research (2012)

Fulltext@MSK | Save

Endocrine biomarkers in response to AR-inhibition with bicalutamide for the treatment of AR(+), ER/PR(-) metastatic breast cancer (MBC) (TBCRC011)

Meeting Abstract

Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J.; Liu, M. C.; Carey, L.; Blackwell, K. L.; Rugo, H.; Nabell, L.; Forero, A.; more...
Cancer Research (2012)

Fulltext@MSK | Save

EGFR and P53 expression in androgen receptor (AR)-positive, triple negative breast cancer (TNBC)

Meeting Abstract

Gucalp, A.; Gupta, G.; Patil, S.; Wen, Y. H.; Akram, M.; Brogi, E.; Powell, S.; Ho, A.; Hudis, C. A.; Traina, T. A.
Annals of Oncology (2012)

Fulltext@MSK | Save

TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR-metastatic breast cancer (MBC)

Meeting Abstract

Gucalp, A.; Tolaney, S. M.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K. L.; Rugo, H. S.; Nabell, L.; Abbruzzi, A.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Expression patterns of receptor activator of nuclear factor-kB (RANK) and Src in a series of primary breast tumors (BT) and bone metastases (BM) in patients (pts) with metastatic breast cancer (MBC)

Meeting Abstract

Gucalp, A.; Comen, E.; Redana, S.; Evangelista, L.; Giri, D. D.; Zhang, X. H.; Patil, S.; Akram, M.; Norton, L.; Hudis, C. A.; more...
Cancer Research (2011)

Fulltext@MSK | Save

Androgen receptor (AR) expression in a cohort of patients (pts) with triple negative breast cancer (TNBC)

Meeting Abstract

Gucalp, A.; Gupta, G.; Patil, S.; Wen, Y. H.; Akram, M.; Brogi, E.; Powell, S. N.; Ho, A. Y.; Hudis, C. A.; Traina, T. A.
Cancer Research (2011)

Fulltext@MSK | Save